Lhasa Limited shared knowledge shared progress
  • Publisher:
    Lhasa Limited and FDA
  • Publication Date:
    Apr 2014
  • Reference:
  • DOI:
  • PMID:
  • Publication Type:
  • Related Products:
  • Scientific Area:
  • Endpoint:
  • Industry Type:
  • Related event:

Reconciling Conflicting (Q)SAR Predictions in Impurity Evaluations.pdf

pdf filePowley MW;

Mark Powley of the Food and Drug Administration presents on the proposed ICH M7 guidelines. The presentation adresses the potential regulatory implications of discordant (Q)SAR predictions and describe strategies used to reconcile such results.

Presented by Mark Powley as part of the 2014 virtual ICGM series; 16th April 2014.


© 2019 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.